Terms ending in 2033
Every in-force patent on Chdi Foundation, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,442,782 | KYNURENINE-3-Monooxygenase Inhibitors, Pharmaceutical Compositions, and Methods of Use Thereof In force · Medium confidence | Chdi Foundation, Inc. | In force | Medium confidence | |
| US 10,501,433 | KYNURENINE-3-Monooxygenase Inhibitors, Pharmaceutical Compositions, and Methods of Use Thereof In force · Medium confidence | Chdi Foundation, Inc. | In force | Medium confidence | |
| US 9,505,736 | Histone Deacetylase Inhibitors and Compositions and Methods of Use Thereof In force · High confidence | Chdi Foundation, Inc. | In force | High confidence | |
| US 9,855,267 | Histone Deacetylase Inhibitors and Compositions and Methods of Use Thereof In force · High confidence | Chdi Foundation, Inc. | In force | High confidence | |
| US 9,822,058 | KYNURENINE-3-Monooxygenase Inhibitors, Pharmaceutical Compositions, and Methods of Use Thereof In force · High confidence | Chdi Foundation, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.